Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiation Therapy Recipient”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableActive Not RecruitingNCT04062305
What this trial is testing

NTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex

Who this might be right for
Metastatic Malignant Neoplasm in the BrainRadiation Therapy Recipient
M.D. Anderson Cancer Center 22
Early research (Phase 1)UnknownNCT03943238
What this trial is testing

TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation

Who this might be right for
Living Donor Kidney Transplantation
Stanford University 22
Post-approval studies (Phase 4)Looking for participantsNCT06734598
What this trial is testing

Efficacy of Botox Injection of the Masticatory Muscles in Head &Neck Cancer Patients with Trismus After Radiotherapy

Who this might be right for
TrismusHead and Neck CancerRadiation Therapy Recipient+1 more
National Taiwan University Hospital 120
Not applicableEnded earlyNCT04110249
What this trial is testing

Photoacoustic Imaging for Measuring Tumors and Normal Tissue in Patients With Head and Neck Cancer

Who this might be right for
Head and Neck CarcinomaHead and Neck Lymph NodeHead and Neck Squamous Cell Carcinoma+2 more
Roswell Park Cancer Institute 14
Very early researchEnded earlyNCT03272633
What this trial is testing

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia in RemissionHematopoietic Cell Transplantation Recipient+16 more
Rutgers, The State University of New Jersey 2
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18